Trial Outcomes & Findings for Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging (NCT NCT02767609)
NCT ID: NCT02767609
Last Updated: 2019-04-30
Results Overview
The relative cerebral blood flow (CBF) in frontal, parietal, occipital gray matter and white matter regions, basal ganglia, thalami, and cerebellum will be measured using region of interest analysis to determine institutional normative values for healthy subjects.
COMPLETED
NA
1 participants
single encounter
2019-04-30
Participant Flow
Participant milestones
| Measure |
Magentic Resonance Imaging
Magnetic Resonance Imaging.
Magnetic Resonance Imaging: All participants will have be given a MRI using a pseudo-continuous arterial spin labeling perfusion sequence.
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
1
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Magentic Resonance Imaging
n=1 Participants
Magnetic Resonance Imaging.
Magnetic Resonance Imaging: All participants will have be given a MRI using a pseudo-continuous arterial spin labeling perfusion sequence.
|
|---|---|
|
Age, Continuous
|
32 years
STANDARD_DEVIATION 0 • n=1 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=1 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=1 Participants
|
|
Region of Enrollment
United States
|
1 participants
n=1 Participants
|
PRIMARY outcome
Timeframe: single encounterPopulation: control
The relative cerebral blood flow (CBF) in frontal, parietal, occipital gray matter and white matter regions, basal ganglia, thalami, and cerebellum will be measured using region of interest analysis to determine institutional normative values for healthy subjects.
Outcome measures
| Measure |
Magentic Resonance Imaging
n=1 Participants
Magnetic Resonance Imaging.
Magnetic Resonance Imaging: All participants will have be given a MRI using a pseudo-continuous arterial spin labeling perfusion sequence.
|
|---|---|
|
Regional Cerebral Blood Flow Values of the Brain Measured Using Pseudo-continuous Arterial Spin Labeling (pCASL) MRI.
|
35.4 ml/100g/min
Standard Deviation 5.7
|
Adverse Events
Magentic Resonance Imaging
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Brenda Bartnik Olson
Loma Linda University medical Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place